What We Offer
Trading Products
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Market
Stocks
Options
Futures
ETF
Forex
Fundamental Tools
Paper Trade
Level 2 Data
Charts
Stock Analysis
Technical Tool
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Paper Trade
Pricing
Pricing
Margin Rate
Promotion
Welcome Bonus
Referral Promotion
Transfer in
Nasdaq Market Depth
Learn Premium
News & Resources
Resources
Learn
Strategies & Insights
moomoo Guide
News
Headlines
Trending Topics
Moomoo Community
Feed
Discussions
Featured Content
About us
About us
Moomoo Foundation Overview
Newsroom
Influencer Program
Investor Relations
Support
Log in
English
中文繁體
中文简体
Download
Mobile
Desktop
Download now
View more versions
Sign up/Log in
English
Back
What We Offer
Trading Products
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Market
Stocks
Options
Futures
ETF
Forex
Fundamental Tools
Paper Trade
Level 2 Data
Charts
Stock Analysis
Technical Tool
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Paper Trade
Pricing
Pricing
Margin Rate
Promotion
Welcome Bonus
Referral Promotion
Transfer in
Nasdaq Market Depth
Learn Premium
News & Resources
Resources
Learn
Strategies & Insights
moomoo Guide
News
Headlines
Trending Topics
Moomoo Community
Feed
Discussions
Featured Content
About us
About us
Moomoo Foundation Overview
Newsroom
Influencer Program
Investor Relations
Support
English
中文繁體
中文简体
Dark
Light
Open Account
Download
Log in to access Online Inquiry
Back to the Top
Verified Account
SteveLai32
liked · 11 hours ago
[Share Link: AbbVie has applied for biological product appro...
AbbVie has applied for biological product approval from the FDA for the treatment of non-small cell lung cancer with tezolizumab-bevacizumab already treated.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
See Original
Report
6 Views
Comment
Sign in
to post a comment
SteveLai32
We Can We Do
5
Followers
60
Following
88
Visitors
Follow
